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To study the roles of Na+-dependent H+ transporters, we characterized H+ efflux
mechanisms in the pancreatic duct in wild-type, NHE2–/–, and NHE3–/– mice. The
pancreatic duct expresses NHE1 in the basolateral membrane, and NHE2 and NHE3 in the
luminal membrane, but does not contain NHE4 or NHE5. Basolateral Na+-dependent H+
efflux in the microperfused duct was inhibited by 1.5 µM of the amiloride analogue HOE
694, consistent with expression of NHE1, whereas the luminal activity required 50 µM HOE
694 for effective inhibition, suggesting that the efflux might be mediated by NHE2. However,
disruption of NHE2 had no effect on luminal transport, while disruption of the NHE3 gene
reduced luminal Na+-dependent H+ efflux by ~45%. Notably, the remaining luminal Na+-
dependent H+ efflux in ducts from NHE3–/– mice was inhibited by 50 µM HOE 694. Hence,
~55% of luminal H+ efflux (or HCO3– influx) in the pancreatic duct is mediated by a novel,
HOE 694–sensitive, Na+-dependent mechanism. H+ transport by NHE3 and the novel
transporter is inhibited by cAMP, albeit to different extents. We propose that multiple Na+-
dependent mechanisms in the luminal membrane of the pancreatic duct absorb Na+ and
HCO3– to produce a pancreatic juice that is poor in HCO3– and rich in Cl– during basal
secretion. Inhibition of the transporters during stimulated secretion aids in producing the
HCO3–-rich pancreatic […]
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Introduction
Pancreatic ducts serve a secretory function to produce a
fluid rich in Na+ and HCO3– in response to secretin
stimulation, and also function as a conduit to carry
pancreatic enzyme and fluid secretions to the intestine
(1). Secretin-stimulated HCO3– secretion across the
luminal membrane (LM) requires H+ secretion or
HCO3– absorption across the basolateral membrane
(BLM) to maintain constant cytosolic pH (pHi) and
replenish the secreted HCO3–. Current evidence sug-
gests that a Na+ and HCO3– cotransporter mediates
most HCO3– influx across the BLM (2, 3). A Na+/H+
exchanger (NHE) in the BLM is assumed to help HCO3–
secretion by controlling pHi to prevent intracellular
acidification during HCO3– secretion (4). Because the
pancreatic duct secretes HCO3– and Na+, NHEs are not
expected to be present in the LM. However, using per-
fused ducts, we and others have reported NHE activity
in the LM of pancreatic ducts of different species (4, 5).
The proteins mediating this activity, their regulation,
and their physiological significance are unknown.
NHEs are a family of membrane proteins involved in
regulation of pHi, cell volume, and electrolyte transport.
Since the initial cloning of NHE1 (6), at least six NHE iso-
forms have been found in mammalian cells; five of these
were identified in rodent tissue (7). The physiological role
of only a few of the isoforms has been established with
any certainty. NHE1 is ubiquitously expressed, and has a
housekeeping role (8). NHE1 is always expressed in the
BLM of epithelial cells (9). In many epithelia, such as sali-
vary glands, small intestine, colon, and kidney, NHE2 and
NHE3 are the major isoforms expressed in the LM (7,
9–11). In the kidney, NHE3 in the proximal tubule medi-
ates 60% of Na+ and HCO3– absorption (12, 13). NHE2 is
believed to mediate a large portion of Na+ absorption in
the small intestine (9). The phenotype of a targeted NHE3
knockout mouse supports a major role for NHE3 in renal
Na+ and HCO3– absorption (14). However, based on the
phenotype of the NHE2–/– mouse, so far the function of
NHE2 appears to be essential only in gastric parietal cells
(15). The role of NHE2 and NHE3 in other tissues that
express these proteins is not known.
The availability of NHE2–/– and NHE3–/– animals pro-
vided an opportunity to clarify the role of these NHE
isoforms and other H+ efflux mechanisms in the
HCO3–-secreting pancreatic duct. We find that NHE1 is
expressed in the BLM, whereas NHE2 and NHE3 are
expressed in the LM. Furthermore, we found a novel
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To study the roles of Na+-dependent H+ transporters, we characterized H+ efflux mechanisms in the
pancreatic duct in wild-type, NHE2–/–, and NHE3–/– mice. The pancreatic duct expresses NHE1 in the
basolateral membrane, and NHE2 and NHE3 in the luminal membrane, but does not contain NHE4
or NHE5. Basolateral Na+-dependent H+ efflux in the microperfused duct was inhibited by 1.5 m M of
the amiloride analogue HOE 694, consistent with expression of NHE1, whereas the luminal activity
required 50 m M HOE 694 for effective inhibition, suggesting that the efflux might be mediated by
NHE2. However, disruption of NHE2 had no effect on luminal transport, while disruption of the
NHE3 gene reduced luminal Na+-dependent H+ efflux by ~ 45%. Notably, the remaining luminal Na+-
dependent H+ efflux in ducts from NHE3–/– mice was inhibited by 50 m M HOE 694. Hence, ~ 55% of
luminal H+ efflux (or HCO3– influx) in the pancreatic duct is mediated by a novel, HOE 694–sensi-
tive, Na+-dependent mechanism. H+ transport by NHE3 and the novel transporter is inhibited by
cAMP, albeit to different extents. We propose that multiple Na+-dependent mechanisms in the lumi-
nal membrane of the pancreatic duct absorb Na+ and HCO3– to produce a pancreatic juice that is poor
in HCO3– and rich in Cl– during basal secretion. Inhibition of the transporters during stimulated
secretion aids in producing the HCO3–-rich pancreatic juice.
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amiloride-sensitive, Na+-dependent H+ efflux (or HCO3–
influx) mechanism that does not correspond to any
known NHE isoform. The use of ducts from wild-type
(WT), NHE2–/–, and NHE3–/– mice showed that NHE3
was responsible for about 45% of the luminal H+ efflux,
and the novel mechanism for about 55%. Despite the
expression of NHE2 in the LM, no functional role for
this isoform could be established. Luminal Na+-depend-
ent H+ efflux mechanisms were decreased by cAMP.
Based on these findings, we proposed a role for luminal
Na+-dependent H+ efflux mechanisms in controlling
electrolyte composition of the pancreatic juice during
basal pancreatic fluid secretion.
Methods
2 ¢ ,7 ¢ -bis-(2-carboxyethyl)-5,6-carboxyfluorescein ace-
toxymethylester (BCECF-AM) was purchased from
Molecular Probes Inc., Eugene, Oregon, USA. HOE 694
was a gift from Hans Lang (Hoechst AG, Frankfurt, Ger-
many). Antibody recognizing NHE1 (16) was a gift from
Sergio Grinstein (Hospital for Sick Children, Toronto,
Canada). Antibody specific for NHE2 (17) was a gift
from Eugene Chang (University of Chicago, Chicago,
Illinois, USA), and antibody specific for NHE3 (12) was
a gift from Orson Moe, University of Texas Southwest-
ern Medical Center, Dallas, Texas, USA.
The standard perfusate was termed pancreatic solu-
tion A, and contained (in mM) 140 NaCl, 5 KCl, 1
MgCl2, 1 CaCl2, 10 HEPES (pH 7.4 with NaOH), and 10
glucose. Na+-free solutions were prepared by replacing
Na+ with N-methyl-D-glucamine.
Animals and preparation of ducts. NHE2 gene–disrupted
(NHE2–/–) or NHE3 gene–disrupted (NHE3–/–) mice
were maintained on a standard diet. Genotyping was
carried out on day 14 postpartum as described previ-
ously (14, 15). Gross microscopic examination did not
reveal any apparent phenotypic abnormalities in the
pancreas of the NHE2–/– mice. The NHE3–/– mice tend-
ed to be smaller than their WT or heterozygote litter-
mates, which may have been a result of their chronic
diarrhea (14). Accordingly, their pancreas also appeared
smaller, but they otherwise had no discernible differ-
ences as judged by microscopic examination.
The procedure for preparation and perfusion of the
main pancreatic duct was identical to that described
previously (18). The animals were anesthetized by intra-
muscular injections of a mixture of ketamine (100
mg/kg) and xylazine (10 mg/kg). The abdomen was
opened and the entry of the common pancreaticobiliary
duct was identified. The lumen was cannulated using a
modified 31-gauge needle (TSK Stri-Ject; Air-Tite Prod-
ucts Co., Virginia Beach, Virginia, USA). After the can-
nula was secured and the proximal end of the common
duct was ligated, the entire pancreas was removed to a
dish containing ice-cold pancreatic solution A, to which
0.02% soybean trypsin inhibitor and 0.1% BSA had been
added. The main duct was cleared of acini and connec-
tive tissue, and the proximal end of the main duct was
cut to facilitate retrograde luminal perfusion.
Measurement of pHi. The microdissected main duct was
transferred to a perfusion chamber placed on the stage
of an inverted microscope equipped with a fluorescence
measuring system (Delta Ram; Photon Technology
International Inc., South Brunswick, New Jersey, USA).
The bath was perfused at a flow rate of 6 mL/min, and
the lumen was perfused at a flow rate of 150 m L/min
using pancreatic solution A at 37°C. The pH-sensitive
fluorescent dye BCECF-AM was loaded through the
luminal perfusate at a concentration of 2 m M in pan-
creatic solution A for 5 minutes. Dye loading was mon-
itored at excitation wavelengths of 490 nm and 440 nm
and an emission wavelength of 525 nm. After comple-
tion of dye loading, pHi measurements were performed
according to the specified protocols, and the fluores-
cence ratios at 490 nm and 440 nm were calibrated
intracellularly by perfusing the cells with solutions con-
taining 145 mM KCl, 10 mM HEPES, and 5 m M
nigericin, with pH adjusted to 6.2–7.6, as described pre-
viously (10). Buffer capacity was calculated by measur-
ing D pHi in response to 5–20 mM NH4Cl pulses (19).
RT-PCR. RT-PCR analysis was performed with rat pan-
creas rather than mouse pancreas, because the sequences
of all the known NHE isoforms are available only for this
species. To avoid contamination with other cell types,
the rat pancreatic duct was carefully microdissected and
cleaned of adherent cells. RNA was extracted from the
microdissected ducts using a guanidinium thio-
cyanate–phenol chloroform solution (TRIzol; GIBCO
BRL, Rockville, Maryland, USA), and was reverse tran-
scribed using random hexamer primers and RNase H–
reverse transcriptase (GIBCO BRL). The cDNA was
amplified using specific primers and AmpliTaq Gold
enzyme (PE Biosystems, Foster City, California, USA);
the products were separated on a 1.5% agarose gel con-
taining 0.1 m g/mL ethidium bromide. Primers were
selected from cDNA sequences of rat NHE1–5 isoforms
(7, 10). The primer sequences were as follows: 
b -actin, sense: 5¢ -CCC TAG ACT TCG AGC AAG AGA TGG-
CCA CTG-3¢ , antisense: 5¢ -CGG ATG TCA ACG TCA CAC TTC-
ATG ATG GAA-3¢ , size of PCR product: 211 bp; 
rNHE1, sense: 5¢ -CCT TTC TGG GGT TTA CAC GGG AGG-
GAC TGT-3¢ , antisense: 5¢ -GTG GAG CTC TGA CTG GCA-
GGG AAG ATT CAA-3¢ , size of PCR product: 160 bp;
1652 The Journal of Clinical Investigation | June 2000 | Volume 105 | Number 11
Figure 1
RT-PCR analysis of NHE isoforms in pancreatic ducts. The rat pan-
creatic duct expresses mRNA for b -actin (211 bp), NHE1 (160 bp),
NHE2 (196 bp), and NHE3 (243 bp), but not for NHE4 and NHE5.
The identity of each of the PCR-amplified products was confirmed
by sequencing.
rNHE2, sense: 5¢ -TGA CGG TAT TAG GGC ACA GGT TGG-
AAT GTA-3¢ , antisense: 5¢ -AAA TTG GGA CAG AGG CGG-
GGG TAA G-3¢ , size of PCR product: 196 bp;
rNHE3, sense: 5¢ -AGG GAG ATC GAG ATG GGG CTA AAG-
GTG GAC-3¢ , antisense: 5¢ -AAG CAG ATG CAG TAT GTT GGG-
CGG ACT TG-3¢ , size of PCR product: 243 bp;
rNHE4, sense: 5¢ -TCT GAG GGT AGG GAT GAT TAA TTG-
GTC ACA-3¢ , antisense: 5¢ -GCA TTG GCC TGT TTC AAC ATT-
TCT GA-3¢ , size of PCR product: 126 bp;
rNHE5, sense: 5¢ -GGC CGA GAC CGA GAG GAT GTG-3¢ ,
antisense: 5¢ -CGG GAT TAG CCA CAC CAT CCT TCT-3¢ , size
of PCR product: 244 bp. 
Positive controls for NHE1, NHE2, and NHE3 were
obtained from submandibular gland mRNA. Positive
controls for NHE4 came from kidney mRNA, and pos-
itive controls for NHE5 were from brain mRNA. The
identities of all amplified products were verified by
nucleotide sequencing.
Immunohistochemistry. The pancreas from WT mice was
embedded in OCT (Miles Inc., Elkhart, Indiana, USA),
frozen in liquid nitrogen, and cut into 4-m m sections.
Pancreatic slices from NHE2–/– or NHE3–/– mice were
also used as negative controls for the respective anti-
bodies and to obtain conclusive evidence for the expres-
sion of each isoform. Immunostaining of frozen sections
was done as reported previously (10). In preliminary
experiments, we tested several tissue fixation, permeabi-
lization, and staining procedures. All harsh fixation pro-
cedures eliminated recognition of the NHE isoforms by
the respective antibodies; therefore the sections were
fixed and permeabilized by incubation with cold
methanol for 10 minutes at –20°C. After removal of
methanol, the slices were washed with PBS twice, and the
tissue area was encircled using a hydrophobic marker
(Pap Pen; Zymed Laboratories Inc., South San Francis-
co, California, USA). The nonspecific sites were blocked
by incubation for 1 hour at room temperature with 0.1
mL PBS containing 5% goat serum, 1% BSA, and 0.1%
gelatin (blocking medium). The medium was aspirated
and then replaced with 50 m L of blocking medium con-
taining control serum and a 1:100 dilution of each anti-
body. After incubation with the primary antibody for 1.5
hours at room temperature, and three washes with PBS,
the antibodies were detected with anti-rabbit goat IgG
tagged with FITC (Jackson ImmunoResearch Laborato-
ries, West Grove, Pennsylvania, USA). Images were col-
lected with a  confocal microscope (MRC 1024; Bio-Rad
Laboratories Inc., Hercules, California, USA).
Data presentation. Data is presented as mean ± SE for
the indicated number of observations (where appropri-
ate). Statistical analysis was determined using ANOVA.
P < 0.05 was considered statistically significant.
Results
Identification of NHE isoforms in the pancreatic duct. The iden-
tities of the NHE isoforms expressed in the pancreatic
duct were first analyzed by RT-PCR. Although secretory
mechanisms may be slightly different between the mouse
and the rat pancreatic ducts, we performed RT-PCR on
rat mRNA because sequence data specific for all NHE iso-
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Figure 2
Immunolocalization of NHE isoforms in murine pancreas. Pancreatic sections were prepared from the indicated mouse lines and then stained
with antibodies specific for NHE1 (a), NHE2 (b), and NHE3 (c). In each image pair, the first image is the phase contrast and the second
image is the corresponding fluorescent image. Because it is difficult to visualize the sparse ducts in the pancreas that are embedded in the
acinar structures without a counterstain, and because counterstaining is not compatible with immunofluorescence, the luminal (LM) and
basal (BLM) borders are highlighted by black lines and marked by arrows in all phase-contrast images.
forms are available only for the rat. To circumvent con-
tamination by other cell types, acinar cells and vessel
structures were removed from the main and interlobular
ducts under microscopic inspection, and the ducts were
washed twice with fresh pancreatic solution A. Figure 1
shows that the pancreatic duct expresses mRNA for
NHE1, NHE2, and NHE3, but not for NHE4 and NHE5.
The ability of the primers for NHE4 and NHE5 to detect
the respective isoforms was verified using mRNA pre-
pared from kidney and brain, respectively (data not
shown). The identity of each of the PCR-amplified prod-
ucts was confirmed by nucleotide sequencing.
Next, we used immunostaining in an attempt to deter-
mine localization of the NHE isoforms. The results
obtained with the mouse pancreas are shown in Figure 2.
The staining with anti-NHE1 antibody in Figure 2a
shows clear basolateral localization and an absence of
luminal staining. However, because more than 95% of the
plasma membrane is BLM, in many ducts staining with
NHE1 appeared to encircle the cells, with occasional
absence of staining in luminal borders. The polyclonal
antibody recognizing NHE2 stained the LM of the duct
(Figure 2b); the specificity of staining was verified by the
absence of a significant signal in pancreatic sections
obtained from NHE2–/– mice. Expression of NHE3 was
localized to the LM of duct cells (Figure 2c), and the speci-
ficity of the staining with this antibody was verified using
the pancreas from NHE3–/– mice. Sections from NHE2–/–
mice showed clear luminal NHE3 staining; those from
NHE3–/– mice showed clear luminal NHE2 staining (data
not shown). However, the signal/noise was not sufficient
to determine whether there was any compensatory incre-
ment of NHE expression in the pancreatic ducts of either
mutant mouse.
Previously, it was shown that both the LM and BLM of
the rat pancreatic duct express functional Na+-depend-
ent H+ efflux activity, which was inhibited by 0.5 mM
amiloride (4). Similar results were found in the mouse
pancreatic duct (Figure 3). Resting pHi of WT pancreat-
ic duct cells was 7.38 ± 0.04 (n = 5) in the absence of
HCO3–. Perfusing the bath with a Na+-free medium
caused a small decrease in pHi, whereas perfusing both
the bath and the lumen with Na+-free medium caused
rapid and intensive acidification. The cells were further
acidified by a luminal application of 20 mM NH4Cl for
1–3 minutes. After removal of NH4+, pHi stabilized at
6.4–6.5. Application of Na+-containing solution to the
bath caused rapid pHi recovery. In five experiments,
HOE 694 at 1.5 m M inhibited the Na+-dependent pHi
recovery by an average of 87% (see Table 1). Among the
known NHE isoforms, only the Ki value for inhibition of
NHE1 by HOE 694 is below 1.5 m M (20). Hence, the
functional data substantiates the immunolocalization
of NHE1 in the BLM. Subsequent application of a medi-
um containing Na+ and 1.5 m M HOE 694 to the lumen
showed that the luminal transporters have a lower affin-
ity for HOE 694 than for the BLM NHE (Figure 3). Mul-
tiple experiments summarized in Table 1 showed that
HOE 694 inhibited luminal NHE activity by 78% at 15
m M, and by 86% at 50 m M.
Identification of the NHE isoform mediating luminal Na+/H+
exchange activity. RT-PCR analysis and immuno-
localization studies suggested the expression of NHE2
and NHE3 in the LM of the mouse pancreatic duct.
Because inhibition of NHE3 in model systems required
a high concentration of HOE 694 (Ki of 0.65 mM), and
50 m M HOE 694 had no effect on luminal NHE activity
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Figure 3
Na+-dependent H+ efflux in the BLM and LM of the pancreatic duct. NHE activity was measured in the main pancreatic duct. After NH4+-
induced acidification, the BLM was perfused with a Na+-containing solution with or without 1.5 m M HOE 694, as indicated. Subsequently,
the LM was perfused with a Na+-containing solution supplemented with the indicated concentration of HOE 694.
Table 1
Inhibition of Na+-dependent pHi recovery by HOE 694
Membrane HOE 694 Inhibition
(m M) (%)
Basolateral 1.5 87 ± 7 (n = 5)
Luminal 1.5 8 ± 3 (n = 5)
Luminal 15.0 78 ± 4 (n = 5)
Luminal 50.0 86 ± 3 (n = 4)
Na+-dependent H+ efflux was measured as described in the legend to Figure 3,
by applying 140 mM Na+ and varying concentrations of HOE 694 to either the
luminal or basal membranes of acidified ducts. The other membrane was per-
fused with a Na+-free solution. The percent inhibition was calculated from the
first derivative of the changes in pHi.
in the mouse proximal tubule (21), we expected NHE2
to be the active isoform in the LM of the pancreatic duct
(9, 20). To obtain unequivocal evidence for the role of
each NHE isoform, we compared NHE activity in pan-
creatic ducts from WT, NHE2–/–, and NHE3–/– mice. Fig-
ure 4a shows representative traces from each mouse line;
Figure 4b shows the summary of at least four experi-
ments under each condition. The rate of luminal Na+-
dependent pHi recovery at an initial pHi of 6.4–6.5 in
ducts from WT mice was 0.93 ± 0.08 pH units/min 
(n = 5). Surprisingly, the rate of luminal Na+-dependent
H+ efflux in pancreatic ducts from NHE2–/– mice was
0.86 ± 0.09 pH units/min (n = 4), which was not signifi-
cantly different from that in WT mice. By contrast, the
rate of luminal Na+-dependent pHi recovery was signifi-
cantly reduced in ducts from NHE3–/– mice (0.51 ± 0.02
pH units/min; n = 6). When interpreting these results, it
is important to consider the buffer capacity of duct cells
in all mouse lines. An increase in buffer capacity in ducts
from NHE3–/– mice could explain the reduced rate of
Na+-dependent pHi recovery. To exclude this possibility,
the buffer capacity of duct cells from WT and NHE
knockout mice was measured. Table 2 shows that there
were no significant differences between the buffer capac-
ity of duct cells from any of these mouse lines.
Of note is the remaining 55% of Na+-dependent H+
efflux in the LM of ducts from NHE3–/– mice, and the
normal activity in ducts from NHE2–/– mice. Therefore,
it was of interest to determine whether these activities
could still be inhibited by HOE 694. Figure 5 shows that
50 m M HOE 694 inhibited the luminal Na+-dependent
H+ efflux by more than 85% in ducts from NHE2–/– and
NHE3–/– mice. Similar results were obtained with three
ducts from each knockout line. Hence, it appears that a
novel Na+-dependent and HOE 694–sensitive mecha-
nism mediates 55% of luminal H+ efflux (or HCO3–
influx) in the mouse pancreatic duct.
Regulation of luminal H+ efflux by cAMP. The main func-
tion of pancreatic duct cells is secretion of an HCO3–-rich
fluid in response to feeding stimuli such as secretin (22).
Having found at least two luminal Na+-dependent H+
efflux mechanisms, we proceeded to determine their pos-
sible regulation by the secretin-generated, second-mes-
senger cAMP. After measuring luminal NHE activity
under basal conditions, duct cells were treated with 5 m M
forskolin and 100 m M 3-isobutyl-1-methylxanthine
(IBMX) for 5 minutes (Figure 6a). Stimulation with
forskolin and IBMX reduced luminal Na+-dependent H+
efflux in ducts from WT mice by 43 ± 5% (n = 5) (Figure
6b). This protocol was also performed with ducts from
NHE2–/– and NHE3–/– mice. Inhibition by forskolin and
IBMX in NHE2–/– mice (45 ± 2%; n = 4) was not different
from that measured in WT mice. The residual activity in
ducts from NHE3–/– mice was also inhibited by cAMP
stimulation, although the inhibition was only 23 ± 6% 
(n = 6). Table 2 shows that inhibition of luminal Na+-
dependent H+ efflux by cAMP was not due to a change in
buffer capacity, because stimulation with forskolin and
IBMX did not change cytoplasmic buffer capacity of pan-
creatic ducts from any of the lines. The effect of cAMP
stimulation on BLM NHE was also investigated. In five
experiments, the BLM NHE activity was not affected by
forskolin and IBMX treatment (data not shown).
Discussion
The major aim of this study was to identify the Na+-
dependent H+ secretory mechanisms in the LM of the
pancreatic duct, and their possible roles in ductal phys-
iology. Immunohistochemistry, backed by RT-PCR
analysis, suggests expression of NHE2 and NHE3 in the
LM of pancreatic duct cells. This is confirmed by the
elimination of staining from the ducts of the respective
knockout mice. The duct also expressed NHE1, which
could be localized by a functional assay (sensitivity to
HOE 694) and immunostaining to the BLM. Therefore,
we can conclude that pancreatic ducts express NHE2
and NHE3 in the LM, and NHE1 in the BLM.
Functional analysis of Na+-dependent H+ transport in
the LM of ducts from WT, NHE2–/–, and NHE3–/– mice
revealed several surprises. The first unexpected finding
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Figure 4
Luminal Na+-dependent H+ efflux in pancreatic ducts of WT, NHE2–/–, and NHE3–/– mice. Luminal Na+-dependent H+ efflux was measured
in ducts acidified to the same level using the indicated protocol. (a) Examples of individual traces from each mouse line. (b) Summary of
five, four, and six experiments performed with ducts from WT, NHE2–/–, and NHE3–/– mice, respectively. AP < 0.05 compared eith WT.
was normal luminal Na+-dependent H+ efflux in ducts
from NHE2–/– mice. From the sensitivity of the activity
to HOE 694 (Table 1) and the reported Ki of the differ-
ent NHE isoforms for inhibition by HOE 694 (20), we
expected that most luminal H+ efflux would be mediat-
ed by NHE2. Several findings confirmed disruption of
the NHE2 gene in the knockout mice. The mice lacked
mRNA coding for WT NHE2, and displayed severe
histopathology of the gastric mucosa and a lack of acid
secretory function (15). Furthermore, the NHE2 protein
was absent from the parotid gland (23), the kidney (21),
and the pancreas (this study). Yet, deletion of NHE2 pro-
tein had no effect on luminal Na+-dependent H+ efflux
in pancreatic duct. Several explanations can account for
this finding. Upregulation of other Na+-dependent
transporters might have offset the effect of deletion of
NHE2. A prediction of this scenario is that the residual
activity in the LM of ducts from NHE2–/– mice will show
different HOE 694 sensitivity than that in LM from
ducts from WT mice. This possibility was excluded by
the finding that 50 m M HOE 694 inhibited more than
85% of luminal Na+-dependent H+ efflux in ducts from
NHE2–/– mice. These findings also suggest that sensitiv-
ity to HOE 694 cannot be used in all cases to discern the
NHE isoform expressed in a given tissue or cell type.
Another alternative explanation for the lack of effect
of deletion of NHE2 is that the NHE2 expressed in the
LM of the pancreatic duct is not active or may not func-
tion as a Na+/H+ exchanger. Some support for this
unconventional interpretation comes from the absence
of any apparent abnormalities in renal, intestinal, or
pancreatic function in the NHE2–/– animals (ref. 15 and
this study). In addition, deletion of NHE2 had no effect
on Na+-dependent H+ efflux in the proximal tubule
(21). Hence, the role of luminal NHE2 in epithelial
physiology remains to be found.
In contrast to the results with NHE2, deletion of the
NHE3 gene reduced luminal pancreatic ductal Na+-
dependent H+ efflux by 45%. The unexpected finding
in this case was the 85–90% inhibition of overall lumi-
nal H+ transport by 50 m M HOE 694. This indicates
that most of the NHE3-mediated activity in the pan-
creatic duct is inhibited by 50 m M HOE 694. Yet, 50 m M
HOE 694 had no effect on Na+-dependent H+ transport
in the LM of the mouse proximal tubule (21). It is
therefore conceivable that the pancreatic duct express-
es an NHE3 splice variant different from that expressed
in the kidney. Further cloning efforts are needed to
examine this possibility. Alternatively, posttranslation-
al modification of NHE3 may confer tissue-specific
sensitivity to HOE 694 (and possibly other amiloride
analogues). This raises further questions regarding the
general use of sensitivity to amiloride and its analogues
as diagnostic tools of NHE isoforms.
An additional unexpected finding was the novel HOE
694–inhibitable; Na+-dependent H+ efflux mechanism in
the LM of pancreatic duct. Recently, we reported analo-
gous activity in the proximal tubule, with the difference
that the renal activity required 100 m M EIPA for maximal
inhibition (21). The particular significance of this activi-
ty is that it mediates as much as 55% of luminal Na+-
dependent H+ efflux. Hence, it may have an important
physiological role in HCO3– absorption in various tissues.
At present, we do not know what protein may mediate
this activity. An obvious possibility is an as-yet unknown
NHE isoform, different from NHE1–5. Additional pos-
sibilities are the newly described Na+ and HCO3– cotrans-
porter NBC3 (24) or a similar isoform. Unique features
of NBC3, when compared with other NBC isoforms, are
that it can transport HCO3– and OH–, it is inhibitable by
amiloride analogues, and it is insensitive to the stilbene
derivative DIDS (24). These features are reminiscent of
those found for the novel luminal Na+-dependent H+ (or
HCO3–) transport in the pancreatic duct (this study) and
proximal tubule (21). We are in the process of evaluating
the contribution of this or a similar transporter to lumi-
nal Na+-dependent H+ efflux.
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Figure 5
The luminal Na+-dependent H+ efflux is inhibited by HOE 694. The
protocol outlined in the legend to Figure 3 was used to measure inhi-
bition of luminal Na+-dependent H+ efflux in pancreatic ducts from
NHE2–/– (upper trace) and NHE3–/– (lower trace) mice.
Table 2
Buffer capacity of mouse pancreatic ducts at pHi 7.0
Resting Forskolin (5 m M)
(D mM NH4+/D pHi)
WT 47.4 ± 5.4 (n = 5) 49.0 ± 5.5 (n = 5)
NHE2–/– 45.9 ± 2.7 (n = 4) 47.1 ± 4.1 (n = 4)
NHE3–/– 45.4 ± 8.7 (n = 4) 42.8 ± 5.6 (n = 4)
In each experiment, the buffer capacity ( b i) showed a negative linear relation-
ship with pHi between 6.3 and 7.3. The b i at pHi = 7.0 was calculated from the
correlative equation.
The pancreatic duct secretes the bulk of HCO3– found
in secretin-stimulated pancreatic juice. Secretin effects
in duct cells are mediated by stimulation of adenylyl
cyclase. It is believed that the increase in cAMP activates
the cystic fibrosis transmembrane conductance regula-
tor (CFTR) to facilitate HCO3– secretion by a Cl–/ HCO3–
exchange mechanism. Na+-dependent H+ secretion was
not expected to be present in the LM of pancreatic ducts,
because it can reduce pancreatic HCO3– and fluid secre-
tion by secreting H+ and absorbing Na+ (and conse-
quently water) from the luminal fluid. Therefore, it was
of particular interest to determine possible regulation of
the luminal NHE transporters by cAMP. Pancreatic
NHE3 and the luminal Na+-dependent H+ efflux trans-
porter are inhibited by a cAMP-dependent mechanism.
Thus, in pancreatic ducts from both WT and NHE2–/–
animals, an increase in cAMP reduced NHE activity by
an average of about 45%. Stimulation with cAMP
reduced the novel Na+-dependent H+ efflux by about
25%, which amounts to about 12.5% of total luminal
Na+-dependent H+ efflux. Thus, cAMP stimulation
inhibited NHE3 activity by about 37.5%. Regulatory
inhibition of NHE3 by cAMP in the kidney proximal
tubule is well understood (25). Protein kinase–mediat-
ed(PKA-mediated) phosphorylation may regulate NHE3
activity directly or through changes in the availability of
NHERF (a PDZ motif containing protein) for interac-
tion with NHE3 (26). In this respect, it is interesting that
NHERF can also downregulate the activity of NBC
transporters (27). Such a mechanism may be related to
the inhibition of the novel Na+-dependent H+ efflux by
cAMP stimulation.
What can the physiological relevance of luminal Na+-
dependent H+ efflux in the HCO3– secreting pancreatic
duct be? A plausible scenario is illustrated in the models
shown in Figure 7. The main pancreatic duct maintains
a resting transepithelial potential difference of –5 mV,
lumen negative (28), and has Na+-leaky tight junctions
(1). The duct also expresses CFTR and has Cl–/HCO3–
exchange activity that is modulated by the PKA-phos-
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Figure 6
Regulation of luminal NHE activity by cAMP. After the control period, ducts were treated with 5 m M forskolin and 100 m M IBMX for 5 min-
utes. (a) A representative experiment using the pancreatic duct of a WT mouse. (b) Summary of the multiple experiments. Forskolin treat-
ment reduced luminal NHE activity by 43 ± 5% (n = 5) in WT mice, 45 ± 2% (n = 6) in NHE2–/– mice, and 23 ± 6% (n = 6) in NHE3–/– mice.
AP < 0.05 compared with WT.
Figure 7
Roles of luminal Na+-dependent H+ efflux mechanisms in pancreatic duct. (a) The resting pancreatic duct maintains a transepithelial volt-
age of –5 mV, lumen negative, and has a leaky tight junction. Hence, Na+ flows from the interstitial space to the luminal space. The luminal
Na+-dependent H+ efflux mechanisms absorb the Na+ in exchange for H+. H+ efflux is equivalent to HCO3– reabsorption, which is secreted
by the basal Cl–/HCO3– exchange activity. (b) When feeding, the gastrointestinal hormone secretin is released from intestinal cells to stimu-
late pancreatic secretion by increasing intracellular cAMP in duct cells. The activity of the luminal Na+-dependent H+ efflux mechanisms are
downregulated by a cAMP-dependent mechanism to reduce Na+-HCO3– reabsorption.
phorylated CFTR (18). The basal Cl–/HCO3– exchange
activity of the pancreatic duct is about 50% of the cAMP-
stimulated activity (18). Basal Cl–/HCO3– exchange and
Na+ leaking through the tight junction will result in a
basal secretion of a fluid rich in Na+ and HCO3–. To pre-
vent loss of Na+ and HCO3– under the basal state, these
ions must be reabsorbed from the luminal fluid. The
Na+-dependent H+ efflux mechanisms described here
can perform this function in a mode analogous to that
used by the proximal tubule to absorb Na+ and HCO3–
(Figure 7a). Na+ and HCO3– absorption will also increase
absorbtion of fluid from the duct lumen. Low pancreat-
ic secretion in the interdigestive basal state is of particu-
lar importance in intermittent feeders such as humans
(22). There is evidence for Na+ and HCO3– absorption by
the duct in the basal state. In fact, basal secretion of
digestive enzymes by acinar cells is about 10% of maxi-
mal. By contrast, basal secretion of HCO3– by the duct is
only 1–2% of maximal. Equally important, the basal
secretory fluid contains high levels of Cl– (22). This sug-
gests that indeed, the pancreatic duct absorbs HCO3–
rather than Cl– under basal conditions.
When feeding, the gastrointestinal hormone secretin is
released from intestinal cells to stimulate pancreatic duc-
tal fluid and HCO3– secretion by increasing cellular cAMP
(1). cAMP activates CFTR (29), which in turn results in
activation of Cl–/HCO3– exchange (18, 30). Consequent-
ly, a large amount of HCO3– is secreted into the lumen,
which is followed by Na+ and water transport through the
leaky tight junctions. The results presented here show
that in parallel with stimulation of HCO3– secretion,
cAMP inhibits Na+-dependent H+ secretion by NHE3 and
the novel luminal efflux mechanism. This will reduce Na+
and HCO3– absorption to allow Cl–/HCO3– exchange and
CFTR to produce HCO3–-rich pancreatic juice.
In summary, we believe that this study highlights an
underappreciated but important function of the pan-
creatic duct: the control of pancreatic secretion and the
composition of the pancreatic juice under basal condi-
tions. It appears that a luminal NHE3 mechanism and a
novel Na+-dependent, amiloride-sensitive H+ efflux
mechanism reabsorb Na+, HCO3–, and fluid, probably to
produce an acidic, Cl–-rich pancreatic juice under resting
conditions. Upon cell stimulation by agonists that act
through cAMP, these mechanisms are inhibited to allow
production of an HCO3–-rich pancreatic juice.
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